Eli Lilly Announces Nearly $1.5 Billion Investment into New Manufacturing Facilities in North Carolina and Ireland

Eli Lilly is sinking almost $1.5 billion into building new manufacturing plants in the US and Ireland to help boost production capacities.

The company is investing $1 billion of the budget into a brand-new manufacturing facility in Concord, North Carolina in the US. The state-of-the-art plant will be dedicated to the manufacture of parenteral (injectable) products and devices using cutting-edge technologies.